WARSAW, Ind., Oct. 28, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced the U.S. Food and Drug Administration (FDA) has ...
Litigation over the Biomet hip replacements has resolved in a global settlement. The result is a plan for several-hundred plaintiffs to receive a base award of $200,000 for each hip they have had ...
iTaperloc® Complete and iG7™ Hip System with Iodine Technology inhibits bacterial adhesion and prevents biofilm formation on the implant surface to help address the issue of Periprosthetic Joint ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback